Synthekine Announces $107.5 Million Oversubscribed Series B Financing To Support Lead Programs To Clinical Proof Of Concept, Advance Preclinical Programs And Platform
Amount Raised
$108 Million
Round Type
Series B
Menlo ParkBiotechnologyHealth CareTherapeuticsDescription
Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has closed an oversubscribed $107.5 million Series B financing. The round was co-led by Deerfield Management and Janus Henderson Investors, with participation from RA Capital Management, Rock Springs Capital, Omega Funds, TCG X, Lilly Asia Ventures, and an undisclosed leading healthcare investor. Existing investors The Column Group, Samsara BioCapital, Canaan Partners, and Emerson Collective also participated in the round.
Quick answer
Synthekine raised $108 Million in a Series B round, dated June 10, 2021. Synthekine is based in Menlo Park, California, United States.
- How much did Synthekine raise?
- Synthekine raised $108 Million in a Series B round on June 10, 2021.
- What does Synthekine do?
- Synthekine Inc. is an engineered cytokine therapeutics company dedicated to developing novel immunotherapies for cancer and inflammatory diseases.
- Where is Synthekine based and how big is it?
- Synthekine is based in Menlo Park, California, United States.
- Who are the decision-makers at Synthekine?
- Fundz holds 1 contact at Synthekine. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Synthekine that raised within 45 days of this round, from Fundz verified event records.
- Turnstone Biologics Corp raised $80M (Series D) on July 21, 2021.
- Amylyx Pharmaceuticals raised $135M (Series C) on July 20, 2021.
- Century Therapeutics raised $11M on July 19, 2021.
- Turnstone Biologics Corp raised $80M on July 14, 2021.
- Nimbus Therapeutics raised $105M (Funding Round) on July 13, 2021.
- Azora Therapeutics, Inc. (DE) raised $500K on July 12, 2021.
Who to call at Synthekine, and when
A new round usually means Synthekine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Synthekine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Synthekine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Synthekine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Synthekine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSynthekine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.